|
KIAA1731 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.51690000455207E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5080000004275E-07 |
| Normal-vs-Stage2 |
7.699800E-03 |
| Normal-vs-Stage3 |
2.127900E-02 |
| Normal-vs-Stage4 |
8.381600E-02 |
| Stage1-vs-Stage2 |
5.278000E-01 |
| Stage1-vs-Stage3 |
2.280400E-01 |
| Stage1-vs-Stage4 |
6.270400E-01 |
| Stage2-vs-Stage3 |
1.855650E-01 |
| Stage2-vs-Stage4 |
4.594400E-01 |
| Stage3-vs-Stage4 |
7.864000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94149999965809E-07 |
| Normal-vs-AfricanAmerican |
1.73680000004062E-06 |
| Normal-vs-Asian |
1.873400E-01 |
| Caucasian-vs-AfricanAmerican |
2.302000E-01 |
| Caucasian-vs-Asian |
5.967400E-01 |
| AfricanAmerican-vs-Asian |
6.557600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18239999960623E-07 |
| Normal-vs-Female |
3.33929999984939E-07 |
| Male-vs-Female |
1.859210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.59319999999408E-05 |
| Normal-vs-Extreme_Weight |
1.86974999999423E-05 |
| Normal-vs-Obese |
3.40109999996674E-06 |
| Normal-vs-Extreme_Obese |
1.948300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.932600E-01 |
| Normal_Weight-vs-Obese |
7.078000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.976000E-01 |
| Extreme_Weight-vs-Obese |
4.785400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.228200E-01 |
| Obese-vs-Extreme_Obese |
4.116000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.319940E-03 |
| Normal-vs-Age(41-60Yrs) |
2.53840004571515E-09 |
| Normal-vs-Age(61-80Yrs) |
3.99159999999732E-05 |
| Normal-vs-Age(81-100Yrs) |
9.916300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.596210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.351980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.186030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.443520E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.474000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48559950399851E-10 |
| Normal-VS-Type2 PRCC |
4.873600E-02 |
| Normal-VS-KIRP CIMP |
6.818100E-02 |
| Normal-VS-Unclassified PRCC |
9.594200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.91746999999021E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.821400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.546400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.719450E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.964100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.035000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.235900E-03 |
| Normal-vs-N1 |
5.043300E-03 |
| Normal-vs-N2 |
7.794800E-01 |
| N0-vs-N1 |
5.906000E-01 |
| N0-vs-N2 |
3.678000E-01 |
| N1-vs-N2 |
2.520200E-01 |
|
|
